Harnessing the dual role of reactive oxygen species in bacterial infection: Therapeutic opportunities for controlled release and targeted modulation.
An integrated therapeutic framework that combines host-directed redox modulation, bacterial ROS sensitization, and engineered intelligent biomaterials is presented, which offers a versatile and translatable platform for the development of next-generation anti-infective therapies.